96 related articles for article (PubMed ID: 28129775)
1. CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer.
Si J; Zhang P; Tian D; Wang X; Ma Y; Zhang J; Wang L; Yang Y
World J Surg Oncol; 2017 Jan; 15(1):34. PubMed ID: 28129775
[TBL] [Abstract][Full Text] [Related]
2. Signaling protein signature predicts clinical outcome of non-small-cell lung cancer.
Jin BF; Yang F; Ying XM; Gong L; Hu SF; Zhao Q; Liao YD; Chen KZ; Li T; Tai YH; Cao Y; Li X; Huang Y; Zhan XY; Qin XH; Wu J; Chen S; Guo SS; Zhang YC; Chen J; Shen DH; Sun KK; Chen L; Li WH; Li AL; Wang N; Xia Q; Wang J; Zhou T
BMC Cancer; 2018 Mar; 18(1):259. PubMed ID: 29510676
[TBL] [Abstract][Full Text] [Related]
3. Correlation of Expression Levels of Copper Transporter 1 and Thymidylate Synthase with Treatment Outcomes in Patients with Advanced Non-small Cell Lung Cancer Treated with S-1/Carboplatin Doublet Chemotherapy.
Konishi M; Imai A; Fujii M; Sugimoto K; Katakami N; Imai Y; Kamoshida S
Asian Pac J Cancer Prev; 2018 Feb; 19(2):435-441. PubMed ID: 29479997
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes associated with neoadjuvant therapy for the treatment of resectable non-small cell lung cancer in real-world practice.
Huang X; Pang G; Mao Z; Li B; Teng Z; Yang Y; Qiu Z; Chen X; Wang P
Clin Respir J; 2024 May; 18(5):e13761. PubMed ID: 38693705
[TBL] [Abstract][Full Text] [Related]
5. Increased HSP27 correlates with malignant biological behavior of non-small cell lung cancer and predicts patient's survival.
Sheng B; Qi C; Liu B; Lin Y; Fu T; Zeng Q
Sci Rep; 2017 Oct; 7(1):13807. PubMed ID: 29062135
[TBL] [Abstract][Full Text] [Related]
6. Modification of Pathologic T Classification for Non-small Cell Lung Cancer With Visceral Pleural Invasion: Data From 1,055 Cases of Cancers ≤ 3 cm.
Liang RB; Li P; Li BT; Jin JT; Rusch VW; Jones DR; Wu YL; Liu Q; Yang J; Yang MZ; Li S; Long H; Fu JH; Zhang LJ; Lin P; Rong TH; Hou X; Lin SX; Yang HX
Chest; 2021 Aug; 160(2):754-764. PubMed ID: 33745993
[TBL] [Abstract][Full Text] [Related]
7. Combined inflammatory parameters and tertiary lymphoid structure predict prognosis in patients with resectable non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy.
Xu F; Zhu H; Dong Y; Li L; Liu N; Yuan S
Front Immunol; 2023; 14():1244256. PubMed ID: 38155965
[TBL] [Abstract][Full Text] [Related]
8. [Survival analysis of 1,742 patients with stage IV non-small cell lung cancer].
Peng H; Ma M; Han B
Zhongguo Fei Ai Za Zhi; 2011 Apr; 14(4):362-6. PubMed ID: 21496437
[TBL] [Abstract][Full Text] [Related]
9. Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy.
Pataer A; Shao R; Correa AM; Behrens C; Roth JA; Vaporciyan AA; Wistuba II; Swisher SG
Cancer Med; 2018 Jun; 7(6):2405-2414. PubMed ID: 29673125
[TBL] [Abstract][Full Text] [Related]
10. Thyroid hormone receptor α1 acts as a new squamous cell lung cancer diagnostic marker and poor prognosis predictor.
Mohamed FEZA; Abdelaziz AO; Kasem AH; Ellethy T; Gayyed MF
Sci Rep; 2021 Apr; 11(1):7944. PubMed ID: 33846395
[TBL] [Abstract][Full Text] [Related]
11. Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial.
Laza-Briviesca R; Cruz-Bermúdez A; Nadal E; Insa A; García-Campelo MDR; Huidobro G; Dómine M; Majem M; Rodríguez-Abreu D; Martínez-Martí A; De Castro Carpeño J; Cobo M; López Vivanco G; Del Barco E; Bernabé Caro R; Viñolas N; Barneto Aranda I; Viteri S; Massuti B; Casarrubios M; Sierra-Rodero B; Tarín C; García-Grande A; Haymaker C; Wistuba II; Romero A; Franco F; Provencio M
Clin Transl Med; 2021 Jul; 11(7):e491. PubMed ID: 34323406
[TBL] [Abstract][Full Text] [Related]
12. Impact of LKB1 status on radiation outcome in patients with stage III non-small-cell lung cancer.
Sitthideatphaiboon P; Nantavithya C; Chantranuwat P; Vinayanuwattikun C; Sriuranpong V
Sci Rep; 2024 Mar; 14(1):6146. PubMed ID: 38480816
[TBL] [Abstract][Full Text] [Related]
13. A retrospective study on the effect of Chinese patent medicine combined with conventional treatment on the survival outcomes of 313 patients with stage II-III NSCLC.
Jia K; Zhang C; Li F; He B; Xie S; Du J; Feng G
Aging (Albany NY); 2024 Mar; 16(7):6212-6228. PubMed ID: 38555532
[TBL] [Abstract][Full Text] [Related]
14. Urinary N1, N12-diacetylspermine is a non-invasive marker for the diagnosis and prognosis of non-small-cell lung cancer.
Takahashi Y; Sakaguchi K; Horio H; Hiramatsu K; Moriya S; Takahashi K; Kawakita M
Br J Cancer; 2015 Nov; 113(10):1493-501. PubMed ID: 26505680
[TBL] [Abstract][Full Text] [Related]
15. Blood regulator of G protein signalling 1 as a potential prognostic biomarker in surgical nonsmall cell lung cancer patients: Correlation with clinical features and survival.
Wang L; Zhang H; Gu X; Wang Y
Clin Respir J; 2024 Jan; 18(1):e13712. PubMed ID: 38081176
[TBL] [Abstract][Full Text] [Related]
16. Tumor Location Is an Independent Prognostic Factor in Completely Resected Pathological Stage I Non-Small Cell Lung Cancer: A Multicenter Retrospective Study.
Kuo WK; Chen PJ; Wu MH; Lee HH; Fan JK; Hsu PH; Weng CF
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730661
[TBL] [Abstract][Full Text] [Related]
17. Expression of CMTM4 shows clinical significance in lung cancer.
Zhu X; Zhang S; Tan S; Li D; Chen X; Kong J; Fu Y; Wang C; Wen L
Transl Cancer Res; 2020 Oct; 9(10):6214-6220. PubMed ID: 35117232
[TBL] [Abstract][Full Text] [Related]
18. Viable tumor cell density after neoadjuvant chemotherapy assessed using deep learning model reflects the prognosis of osteosarcoma.
Kawaguchi K; Miyama K; Endo M; Bise R; Kohashi K; Hirose T; Nabeshima A; Fujiwara T; Matsumoto Y; Oda Y; Nakashima Y
NPJ Precis Oncol; 2024 Jan; 8(1):16. PubMed ID: 38253709
[TBL] [Abstract][Full Text] [Related]
19. CMTM family proteins 1-8: roles in cancer biological processes and potential clinical value.
Wu J; Li L; Wu S; Xu B
Cancer Biol Med; 2020 Aug; 17(3):528-542. PubMed ID: 32944388
[TBL] [Abstract][Full Text] [Related]
20. A novel protein CMTM1-v5 specifically induced human lymphoma cells apoptosis in vitro and in vivo.
Cao L; Yang C; Zhu B; Zhang G; Zhao N; Liu X; Ke X; Chen W; Wang J; Wang L
Exp Cell Res; 2019 Dec; 385(1):111623. PubMed ID: 31542285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
